✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
In this report we present spinal anesthesia that was administered to a patient with Hunter syndrome to avoid complications related to anticipated difficult airway.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Mucopolysaccharidosis type II (MPS II, Hunter syndrome) is a rare X-linked lysosomal storage disorder caused by a deficiency of the enzyme iduronate-2-sulphatase, leading to the accumulation of glycosaminoglycan (GAG).
📊
Key Findings & Data:GAG accumulation causes difficult airway due to changes in the upper airway.
💡
Conclusion & Impact:In this report we present spinal anesthesia that was administered to a patient with Hunter syndrome to avoid complications related to anticipated difficult airway.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
Mucopolysaccharidosis type II (MPS II, Hunter syndrome) is a rare X-linked lysosomal storage disorder caused by a deficiency of the enzyme iduronate-2-sulphatase, leading to the accumulation of glycosaminoglycan (GAG). GAG accumulation causes difficult airway due to changes in the upper airway. In this report we present spinal anesthesia that was administered to a patient with Hunter syndrome to avoid complications related to anticipated difficult airway.
🔖
Cite This Article
ALTUNKAYA, N., ASLAN, D. D. (2019). Successful use of spinal anesthesia for incarcerated inguinal hernia repair in a patient with Hunter syndrome. Medicine Science, Cilt: 8 - Sayı: 3, 754–755. https://ajindex.com/articles/277139